-
Illumina Announces Fourth Quarter and Fiscal Year 2025 Financial Performance
NASDAQ: $ILMN Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025 Illumina, Inc. today announced its financial results for the fourth quarter and fiscal year ended December 31, 2025. The company reported solid performance across its core sequencing segments, reflecting continued momentum in both clinical adoption and research applications globally. Fourth Quarter Financial…
-
Pharos AI and 10x Genomics Join Forces to Advance Cancer Research Through Integrated Technology
NASDAQ: $TXG A significant collaboration has been established between Pharos AI, a leader in artificial intelligence solutions for the life sciences, and 10x Genomics, a pioneer in single cell and spatial biology technologies. This partnership is set to revolutionize how researchers approach complex challenges in oncology by integrating advanced computational power with cutting-edge molecular analysis.…